Biography

Dr. Signe Michel

Dr. Signe Michel

Non-Executive Director

Dr. Signe Michel

Signe joined the Hyperion Board in July 2018 following CDPQ’s investment in the Group. Signe has over ten years’ experience in strategy consulting and private equity investing. She joined CDPQ’s private equity team in London in 2017 where she focuses on investments in Northern Europe. Before joining CDPQ, Signe spent five years with Permira, first in Frankfurt and in 2014 joined Permira’s office in London. Signe also serves on the board of Datamars.

Signe started her career as a strategy consultant with BCG and holds an MBA from Columbia Business School, NY as well as a doctorate degree in neurophysiology from the University of Zurich.